Cardiff Oncology Newsroom

Craig-Hallum Maintains Cardiff Oncology(CRDF.US) With Buy Rating, Announces Target Price $10

Futu NewsDec 17, 2024 22:31

Cardiff Oncology Is Maintained at Overweight by Piper Sandler

Dow JonesDec 13, 2024 21:24

Cardiff Oncology Analyst Ratings

BenzingaDec 13, 2024 21:14

Piper Sandler Maintains Cardiff Oncology(CRDF.US) With Buy Rating, Raises Target Price to $10

Futu NewsDec 13, 2024 20:31

TD Cowen Maintains Cardiff Oncology(CRDF.US) With Buy Rating

Futu NewsDec 13, 2024 20:31

Craig-Hallum Maintains Cardiff Oncology(CRDF.US) With Buy Rating

Futu NewsDec 10, 2024 22:31

Cardiff Oncology (CRDF) Gets a Buy From Craig-Hallum

TipRanksDec 10, 2024 21:59

Cardiff Oncology Is Maintained at Buy by HC Wainwright & Co.

Dow JonesNov 9, 2024 03:40

Cardiff Oncology Analyst Ratings

BenzingaNov 9, 2024 03:31

H.C. Wainwright Maintains Cardiff Oncology(CRDF.US) With Buy Rating, Cuts Target Price to $13

Futu NewsNov 8, 2024 20:35

TD Cowen Maintains Cardiff Oncology(CRDF.US) With Buy Rating

Futu NewsNov 8, 2024 12:31

TD Cowen Reaffirms Their Buy Rating on Cardiff Oncology (CRDF)

TipRanksNov 8, 2024 12:29

Craig-Hallum Maintains Cardiff Oncology(CRDF.US) With Buy Rating, Maintains Target Price $8

Futu NewsSep 11, 2024 21:31

Cardiff Oncology Analyst Ratings

BenzingaSep 6, 2024 20:27

Craig-Hallum Initiates Cardiff Oncology(CRDF.US) With Buy Rating, Announces Target Price $8

Futu NewsSep 6, 2024 19:33

HC Wainwright & Co. : The Cardiff Oncology (CRDF.US) rating was reaffirmed and adjusted from buy to buy, with a target price of $14.00.

Zhitong FinanceMay 6, 2024 18:31

Cardiff Oncology Analyst Ratings

BenzingaMay 6, 2024 18:31

HC Wainwright & Co. Reiterates Buy on Cardiff Oncology, Maintains $14 Price Target

BenzingaMay 6, 2024 18:30

Cardiff Oncology (CRDF) Gets a Buy From Piper Sandler

TipRanksMay 3, 2024 20:25

Cardiff Oncology Analyst Ratings

BenzingaMar 6, 2024 19:50